Is my portfolio
One Report to Answer all your Questions!
Alivus Life Sciences Ltd.
BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
898.00
8.40 (0.94%) Glenmark Life Sciences informs about offer letter
Date: 09-02-2024Glenmark Life Sciences has informed that DAM Capital Advisors (Manager to the Offer) has submitted a copy of Letter of Offer to the Public Shareholders of Glenmark Life Sciences (Target Company).
The above information is a part of company’s filings submitted to BSE.